已核实 DOI PubMed 相关产品: 2

Activation of Nrf2/HO-1 signaling pathway exacerbates cholestatic liver injury

Journal 2024 · IF 5.2 · 7(1): 1-17 · 发表于 2024 年 5 月 23 日
作者: Wang Yi,Fu Xiaolong,Zeng Li,Hu Yan,Gao Rongyang,Xian Siting,Liao Songjie,Huang Jianxiang,Yang Yonggang,Liu Jilong,Jin Hai,Klaunig James,Lu Yuanfu,Zhou Shaoyu
阅读全文 在 PubMed 查看

摘要

Nuclear factor erythroid 2-related factor-2 (Nrf2) antioxidant signaling is involved in liver protection, but this generalization overlooks conflicting studies indicating that Nrf2 effects are not necessarily hepatoprotective. The role of Nrf2/heme oxygenase-1 (HO-1) in cholestatic liver injury (CLI) remains poorly defined. Here, we report that Nrf2/HO-1 activation exacerbates liver injury rather than exerting a protective effect in CLI. Inhibiting HO-1 or ameliorating bilirubin transport alleviates liver injury in CLI models. Nrf2 knockout confers hepatoprotection in CLI mice, whereas in non-CLI mice, Nrf2 knockout aggravates liver damage. In the CLI setting, oxidative stress activates Nrf2/HO-1, leads to bilirubin accumulation, and impairs mitochondrial function. High levels of bilirubin reciprocally upregulate the activation of Nrf2 and HO-1, while antioxidant and mitochondrial-targeted SOD2 overexpression attenuate bilirubin toxicity. The expression of Nrf2 and HO-1 is elevated in serum of patients with CLI. These results reveal an unrecognized function of Nrf2 signaling in exacerbating liver injury in cholestatic disease.

本研究中使用的阿拉丁产品

2 款产品在本文中被引用